Market Place
Sourcing Support
All News #Library
Biotech
Alligator Bioscience Reacts To Henlius` HLX49 Preclinical Data
23 Apr 2026 //
PHARMIWEB
Eisai, Henlius Ink Exclusive Deal For Anti-PD-1 Antibody In Japan
05 Feb 2026 //
PR NEWSWIRE
At JPM 2026, Henlius Showcases "Globalisation 2.0" Strategy
16 Jan 2026 //
PR NEWSWIRE
FDA Approves POHERDY® as First PERJETA Biosimilar
17 Nov 2025 //
BUSINESSWIRE
Forlong Biotech In Collaboration With Henlius For Cancer
22 Oct 2025 //
BUSINESSWIRE
HANSIZHUANG Ph3 Trial Meets Goal in Gastric Cancer, NDA Planned
09 Oct 2025 //
PR NEWSWIRE
EC Approves Henlius, Organon`s BILDYOS & BILPREVDA Biosimilars
19 Sep 2025 //
PHARMAWEB
FDA Approves Henlius and Organon`s Bildyos and Bilprevda
02 Sep 2025 //
PHARMAWEB
Henlius pens $202M pact for HanchorBio`s midstage CD47 blocker
02 Jul 2025 //
PR NEWSWIRE
HanchorBio, Henlius Ink Deal to Boost Immuno-Oncology with HCB101
01 Jul 2025 //
PR NEWSWIRE
Sandoz partners with Henlius to commercialize ipilimumab
29 Apr 2025 //
GLOBENEWSWIRE
Alligator Bioscience starts HLX22 Phase 2 trial in breast cancer
23 Apr 2025 //
ACCESSWIRE
Henlius & Dr. Reddy`s Ink Licensing Deal for HLX15 Expansion in Europe & US
07 Feb 2025 //
PRESS RELEASE
Serplulimab Approved in EU for First-Line ES-SCLC Treatment
05 Feb 2025 //
PR NEWSWIRE
Alligator Doses First Patient in Henlius Phase 3 Trial
04 Dec 2024 //
ACCESSWIRE
FDA Accepts BLA for HLX14, Biosimilar Candidate of PROLIA/XGEVA
30 Oct 2024 //
BUSINESSWIRE
Primary Endpoint Met In Ph 3 Study Of Perjeta Biosimilar HLX11
30 Sep 2024 //
PRESS RELEASE
EMA validates Henlius & Organon’s Mkg authorization for Prolia& Xgeva biosimilar
27 May 2024 //
PHARMIWEB
Henlius to Release the Preclinical Profiles of 2 ADC Programs at ESMO Congress
21 Sep 2023 //
PRESS RELEASE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.